ANEST IWATA Corporation
Notice Regarding Share Buyback Status
From August 1, 2026 to August 31, 2026 (on a trade basis), 273,800 ordinary shares were acquired via market purchases, with a total acquisition value of 519,228,600 yen. For reference, at the Board of Directors meeting on May 12, the up-to-1,000,000 shares and up-to-15 billion yen were approved, and cumulative acquisitions total 824,600 shares for 1,462,807,300 yen.
Key Figures
- 273,800 shares: acquired shares (period: 2026/08/01〜2026/08/31)
- 519,228,600 yen: total acquisition value
- 824,600 shares: cumulative acquired shares (as of 2026/08/31)
AI要約
Overview of share buyback
Anest Iwata conducted a share buyback of ordinary shares in accordance with the Companies Act. From August 1 to August 31, 2026, 273,800 shares were acquired via market purchases, with a total acquisition value of 519,228,600 yen. Additionally, based on the approved cap at the May 12 Board meeting (1,000,000 shares and up to 15 billion yen), cumulative acquisitions amount to 824,600 shares and 1,462,807,300 yen.
Background and expected impact
The share buyback is part of shareholder return measures, potentially aiming to reduce dilution and enhance shareholder value. The acquisition period is limited, and future additional acquisitions depend on a Board resolution update. The use of market purchases is a notable feature.
Anest Iwata Corporation
Company overview · Stock price · Financial data · All IR
